Integrated DNA Technologies Opens New San Diego Oligonucleotide Product Center
IDT Brings Industry-Leading Quality, and Next-Day Oligo Production to California's Biotech Hub
Coralville, IA - Already the largest supplier of custom nucleic acids in the U.S., Integrated DNA Technologies (IDT) further expanded its oligonucleotide production capabilities with the official opening of IDT West Coast Operations in San Diego. Participating at the event were San Diego Regional Economic Development Corporation CEO Julie Meier Wright, and Joe Panetta, CEO of BIOCOM who joined IDT President Dr. Joseph Walder in cutting the ribbon that marks the company's arrival in one of the nation's key biotech communities.
IDT West Coast Operations gives the California biotech industry immediate access to IDT's next-day oligo production capability and allows the company to further capitalize on its increasing market share.
"San Diego has built a great reputation as one of the world's leading biotech centers," noted San Diego Regional EDC's CEO Julie Meier Wright. "IDT's decision to locate its first satellite production facility here is a testament to the vibrancy of our life science and research community. We look forward to working with the new IDT West Coast Operation as they use their expertise to enhance the quality of research undertaken across the region."
The establishment of IDT West Coast Operations represents the latest step in a new phase of growth for Integrated DNA Technologies. As Dr. Walder said, "The San Diego biotech industry continues to expand and improve. Given its growing needs, and the quality of work undertaken across this region, we recognized the value in establishing a physical presence here. IDT West Coast Operations allows us to add a locally accessible next-day order fulfillment service to the product and support quality we have always provided our customers."
IDT West Coast Operations is the result of Integrated DNA Technologies acquisition of San Diego based GenBase, Inc. in December 2005. GenBase's facility was absorbed into IDT's new 10,000 sq. ft. production center and the Coralville, Iowa based company has moved to quickly introduce its own proprietary custom nucleic acid production equipment and processes. Currently IDT West Coast Operations employs 16 people, and plans to double that number within the next 12 months.
"Researchers know that IDT represents the best in oligo synthesis, quality assurance, and customer support," said Dan Dernbach, recently appointed general manager of IDT's new division. "Now, with our new West Coast Operations we've brought that quality standard and QC excellence to the next-day service sector at the heart of California's oligo market."
IDT is also expanding its headquarters in Coralville, Iowa with a 77,000 square foot extension, due for completion in February. Effectively doubling that center's research, support and production capacity, the new expansion will allow IDT to better cater to increasing market demand for its products by augmenting its customer service and order fulfillment departments.
IDT's Coralville headquarters - the foundation for the company's continued growth over the past decade - currently supports the employment of 338 local area residents. The new expansion is expected to increase that number by up to 50% over the next 24 months.
From its headquarters in Coralville, its new production center in San Diego, and its satellite offices in Illinois, Toronto, and Israel, IDT serves the areas of academic research, biotechnology, and pharmaceutical development by manufacturing the highest quality custom nucleic acids at competitive prices, and delivering the fastest order turnaround times.
SOURCE: Integrated DNA Technologies